KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Leases (2019 - 2025)

Historic Current Leases for Fulgent Genetics (FLGT) over the last 7 years, with Q3 2025 value amounting to $1.5 million.

  • Fulgent Genetics' Current Leases rose 40.51% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 40.51%. This contributed to the annual value of $1.4 million for FY2024, which is 6353.3% down from last year.
  • Per Fulgent Genetics' latest filing, its Current Leases stood at $1.5 million for Q3 2025, which was up 40.51% from $1.2 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Current Leases high stood at $6.1 million for Q4 2022, and its period low was $1.0 million during Q2 2021.
  • Its 5-year average for Current Leases is $2.3 million, with a median of $1.5 million in 2025.
  • As far as peak fluctuations go, Fulgent Genetics' Current Leases surged by 25742.19% in 2021, and later plummeted by 6353.3% in 2024.
  • Fulgent Genetics' Current Leases (Quarter) stood at $1.8 million in 2021, then soared by 235.08% to $6.1 million in 2022, then plummeted by 35.47% to $4.0 million in 2023, then plummeted by 63.53% to $1.4 million in 2024, then increased by 3.05% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.